These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16284457)

  • 1. Indirubin-3'-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication.
    Heredia A; Davis C; Bamba D; Le N; Gwarzo MY; Sadowska M; Gallo RC; Redfield RR
    AIDS; 2005 Dec; 19(18):2087-95. PubMed ID: 16284457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex.
    Biglione S; Byers SA; Price JP; Nguyen VT; Bensaude O; Price DH; Maury W
    Retrovirology; 2007 Jul; 4():47. PubMed ID: 17625008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the HIV-1 positive elongation factor P-TEFb and inhibitors thereof.
    Wang Y; Liu XY; De Clercq E
    Mini Rev Med Chem; 2009 Mar; 9(3):379-85. PubMed ID: 19275730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of CDK9 with indirubin 3'-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice.
    Medina-Moreno S; Dowling TC; Zapata JC; Le NM; Sausville E; Bryant J; Redfield RR; Heredia A
    PLoS One; 2017; 12(8):e0183425. PubMed ID: 28817720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of flavopiridol analogues that selectively inhibit positive transcription elongation factor (P-TEFb) and block HIV-1 replication.
    Ali A; Ghosh A; Nathans RS; Sharova N; O'Brien S; Cao H; Stevenson M; Rana TM
    Chembiochem; 2009 Aug; 10(12):2072-80. PubMed ID: 19603446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of P-TEFb at sites of dual HIV/TB infection, and inhibition of MTB-induced HIV transcriptional activation by the inhibitor of CDK9, Indirubin-3'-monoxime.
    Toossi Z; Wu M; Hirsch CS; Mayanja-Kizza H; Baseke J; Aung H; Canaday DH; Fujinaga K
    AIDS Res Hum Retroviruses; 2012 Feb; 28(2):182-7. PubMed ID: 21453127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavopiridol inhibits P-TEFb and blocks HIV-1 replication.
    Chao SH; Fujinaga K; Marion JE; Taube R; Sausville EA; Senderowicz AM; Peterlin BM; Price DH
    J Biol Chem; 2000 Sep; 275(37):28345-8. PubMed ID: 10906320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors.
    Wang D; de la Fuente C; Deng L; Wang L; Zilberman I; Eadie C; Healey M; Stein D; Denny T; Harrison LE; Meijer L; Kashanchi F
    J Virol; 2001 Aug; 75(16):7266-79. PubMed ID: 11461999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).
    Chiu YL; Cao H; Jacque JM; Stevenson M; Rana TM
    J Virol; 2004 Mar; 78(5):2517-29. PubMed ID: 14963154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential use of pharmacological cyclin-dependent kinase inhibitors as anti-HIV therapeutics.
    Pumfery A; de la Fuente C; Berro R; Nekhai S; Kashanchi F; Chao SH
    Curr Pharm Des; 2006; 12(16):1949-61. PubMed ID: 16787240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of CYC202 in HIV-1-infected cells.
    Agbottah E; de La Fuente C; Nekhai S; Barnett A; Gianella-Borradori A; Pumfery A; Kashanchi F
    J Biol Chem; 2005 Jan; 280(4):3029-42. PubMed ID: 15531588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host-cell positive transcription elongation factor b kinase activity is essential and limiting for HIV type 1 replication.
    Flores O; Lee G; Kessler J; Miller M; Schlief W; Tomassini J; Hazuda D
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7208-13. PubMed ID: 10377393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.
    Zhou M; Deng L; Lacoste V; Park HU; Pumfery A; Kashanchi F; Brady JN; Kumar A
    J Virol; 2004 Dec; 78(24):13522-33. PubMed ID: 15564463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirubin-3'-monoxime exhibits potent antiviral and anti-inflammatory effects against human adenoviruses in vitro and in vivo.
    Wang J; Yang C; Liang Z; Sun J; Zhang M; Qiu S; Du X; He X; Pang X; Ma X; Xie M; Han X; Fan R; Zhou E; Yu H; She D; Song H; Wang J
    Biomed Pharmacother; 2024 May; 174():116558. PubMed ID: 38603887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes.
    Salerno D; Hasham MG; Marshall R; Garriga J; Tsygankov AY; Graña X
    Gene; 2007 Dec; 405(1-2):65-78. PubMed ID: 17949927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
    Fujinaga K; Irwin D; Geyer M; Peterlin BM
    J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins.
    Schang LM; Bantly A; Knockaert M; Shaheen F; Meijer L; Malim MH; Gray NS; Schaffer PA
    J Virol; 2002 Aug; 76(15):7874-82. PubMed ID: 12097601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function.
    Liou LY; Herrmann CH; Rice AP
    J Virol; 2002 Nov; 76(21):10579-87. PubMed ID: 12368300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
    Zhou Q; Chen D; Pierstorff E; Luo K
    EMBO J; 1998 Jul; 17(13):3681-91. PubMed ID: 9649438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of cdk-9 inhibitor activity against HIV-1 replication among various models of chronic and latent infection.
    Pisell TL; Ho O; Lee G; Butera ST
    Antivir Chem Chemother; 2001; 12 Suppl 1():33-41. PubMed ID: 11594686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.